mRNA cancer vaccines show therapeutic potential for malignant tumors, including hepatocellular carcinoma (HCC). We optimized and synthesized stable mRNA encoding costimulator Oxford 40 ligand (OX40L). For systemic delivery, OX40L mRNAs were loaded into lipid nanoparticles (LNPs). The expression and costimulatory effects of OX40L were investigated . OX40L was expressed on the cell surface and costimulated T cells. , intratumoral injection of LNPs encapsulating OX40L mRNAs significantly reduced tumor growth and increased the survival of mice bearing H22 tumors. Importantly, CD4+ and CD8+ T cells were significantly increased in the OX40L mRNA group . Taken together, our findings provide a promising clinical strategy for immunotherapy for HCC using mRNA vaccines.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9606466PMC
http://dx.doi.org/10.3389/fonc.2022.975408DOI Listing

Publication Analysis

Top Keywords

ox40l mrna
8
hepatocellular carcinoma
8
ox40l mrnas
8
ox40l
7
mrna vaccine
4
vaccine inhibits
4
inhibits growth
4
growth hepatocellular
4
mrna
4
carcinoma mrna
4

Similar Publications

Atopic dermatitis (AD) is among the most frequently encountered skin diseases, bothering a considerable number of patients. Today, corticosteroids and antihistamines are among the numerous drugs applied for the therapy of AD. However, lengthy use of them contributes to side effects, such as physiological changes in skin.

View Article and Find Full Text PDF
Article Synopsis
  • Blocking IL-13 is effective for treating atopic dermatitis (AD), and new research suggests that targeting T cell costimulatory molecules like OX40 and OX40L could also be a beneficial treatment option.
  • This study investigates whether targeting CD30L might be an additional therapeutic avenue, by comparing it with existing targets like IL-13 and OX40L using single-cell RNA-seq and a murine model of AD.
  • Results showed that blocking CD30L effectively reduced disease symptoms in mice, indicating that targeting the CD30-CD30L pathway could be a promising future treatment for human atopic dermatitis, similar to targeting the OX40-OX40L pathway.
View Article and Find Full Text PDF
Article Synopsis
  • The study explores the challenge of treating head and neck tumors due to their low radiosensitivity and investigates whether small molecule kinase inhibitors (smKIs) can enhance the effectiveness of radiotherapy by altering immune-related factors in tumor cells.
  • The researchers combined ATM and ATR inhibitors with a specific radiotherapy regimen and examined various effects, including tumor cell death, immune checkpoint marker expression, and cytokine release using cell lines with different HPV statuses.
  • Results showed that while the combination therapy effectively induced cell death, particularly with ATR inhibitors, it also altered the immune profile of surviving cancer cells, suggesting a complex interaction between treatment types and immune responses.
View Article and Find Full Text PDF

Differential expression of immune checkpoints (OX40/OX40L and PD-1/PD-L1) in decidua of unexplained recurrent spontaneous abortion women.

Hum Immunol

January 2024

Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou, China; Jiangsu Institute of Clinical Immunology & Jiangsu Key Laboratory of Clinical Immunology, The First Affiliated Hospital of Soochow University, Suzhou, China. Electronic address:

In this study, we aimed to investigate the expression of OX40, OX40L, PD-1 and PD-L1 in patients with unexplained recurrent spontaneous abortion (URSA) compared to normal pregnancies (NP). A total of 50 patients who were diagnosed with URSA and 41 NP were recruited to this study. Real-time polymerase chain reaction (RT-PCR) was used to determine the expression of OX40, OX40L, PD-1 and PD-L1 in decidual tissues; Immunohistochemistry (IHC) was conducted to characterize the distribution of the involved genes in decidual tissues; Double immunofluorescence staining was used to prove the localization of the involved genes in decidual tissues.

View Article and Find Full Text PDF

Amygdalin Improves Allergic Asthma via the Thymic Stromal Lymphopoietin-dendritic Cell-OX40 Ligand Axis in a Mouse Model.

Iran J Allergy Asthma Immunol

October 2023

Department of Pediatrics, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Asthma, characterized by persistent inflammation and increased sensitivity of the airway, is the most common chronic condition among children. Novel, safe, and reliable treatment strategies are the focus of current research on pediatric asthma. Amygdalin, mainly present in bitter almonds, has anti-inflammatory and immunoregulatory potential, but its effect on asthma remains uninvestigated.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!